Zosuquidar (LY335979) is a P-glycoprotein (P-gp) inhibitor (Ki=59 nM). Zosuquidar shows anti-tumor activities, and can be used in acute myelogenous leukemia (AML) research[1][2][3].
Molecular Weight:
527.60
Purity:
99.90
CAS Number:
[167354-41-8]
Formula:
C32H31F2N3O2
Target:
P-glycoprotein
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted